Skip to main content

Table 4 Patients offered primary SLNB according to final pathology and breast surgery type

From: Necessity of sentinel lymph node biopsy in ductal carcinoma in situ patients: a retrospective analysis

 

BCS (n = 145)

TM (n = 162)

DCIS

Invasive cancer

DCIS

Invasive cancer

SLNB (n = 202)

38

16

107

41

No SLNB (n = 105)

89

2

14

0

 

127 (87.6%)

18 (12.4%)

121 (74.7%)

41 (25.3%)

  1. BCS breast-conserving surgery, DCIS ductal carcinoma in situ, SLNB sentinel lymph node biopsy, TM total mastectomy
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us